T.Man Pharmaceutical PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	2,220	2,213	1,972	2,017	1,260	895.52
Other Revenue	16.3	13.35	7.81	8.05	3.43	5.26
Revenue	2,236	2,226	1,980	2,025	1,263	900.78
Revenue Growth (YoY)	7.02%	12.42%	-2.20%	60.26%	40.25%	-
Cost of Revenue	1,141	1,133	1,003	923.57	861.26	572.32
Gross Profit	1,095	1,093	976.84	1,101	402.08	328.46
Selling, General & Admin	562.7	546.65	496.43	452.32	313.35	248.35
Operating Expenses	561.1	543.35	451.8	492.88	321.07	254.23
Operating Income	534.03	549.98	525.04	608.21	81.01	74.23
Interest Expense	-22.94	-18.63	-14.85	-16.98	-7.18	-9.09
Pretax Income	511.1	531.36	510.19	591.23	73.83	65.15
Income Tax Expense	78	80.65	79.1	118.71	17.44	5.25
Earnings From Continuing Operations	433.1	450.7	431.09	472.52	56.39	59.89
Minority Interest in Earnings	-0	-0	-0	-	-	-
Net Income	433.1	450.7	431.09	472.52	56.39	59.89
Net Income to Common	433.1	450.7	431.09	472.52	56.39	59.89
Net Income Growth	-2.77%	4.55%	-8.77%	737.91%	-5.84%	-
Shares Outstanding (Basic)	361	343	275	250	72	67
Shares Outstanding (Diluted)	361	343	275	250	72	67
Shares Change (YoY)	22.40%	24.68%	10.30%	246.21%	8.20%	-
EPS (Basic)	1.20	1.31	1.56	1.89	0.78	0.90
EPS (Diluted)	1.20	1.31	1.56	1.89	0.78	0.90
EPS Growth	-20.56%	-16.14%	-17.29%	142.02%	-12.98%	-
Free Cash Flow	340.51	345.71	62.15	289.02	196.49	128.83
Free Cash Flow Per Share	0.94	1.01	0.23	1.16	2.72	1.93
Dividend Per Share	0.200	0.200	0.036	-	-	-
Dividend Growth	455.56%	455.56%	-	-	-	-
Gross Margin	48.98%	49.12%	49.33%	54.38%	31.83%	36.46%
Operating Margin	23.89%	24.71%	26.52%	30.04%	6.41%	8.24%
Profit Margin	19.37%	20.25%	21.77%	23.34%	4.46%	6.65%
Free Cash Flow Margin	15.23%	15.53%	3.14%	14.27%	15.55%	14.30%
EBITDA	634.04	645.11	611.56	678.68	148.29	143.51
EBITDA Margin	28.36%	28.98%	30.89%	33.52%	11.74%	15.93%
D&A For EBITDA	100	95.12	86.52	70.48	67.28	69.28
EBIT	534.03	549.98	525.04	608.21	81.01	74.23
EBIT Margin	23.89%	24.71%	26.52%	30.04%	6.41%	8.24%
Effective Tax Rate	15.26%	15.18%	15.50%	20.08%	23.62%	8.06%
Revenue as Reported	2,236	2,226	1,980	2,025	1,263	900.78
Advertising Expenses	-	113	97	89	52	34

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.